Literature DB >> 4415197

Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis.

G S Uhl, J L Baldwin, F C Arnett.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4415197

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  7 in total

1.  Therapeutic quandary: asymptomatic primary biliary cirrhosis associated with polymyositis.

Authors:  R A Willson
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

2.  Polymyositis and acute onset systemic sclerosis in a patient with primary biliary cirrhosis: a clinical syndrome similar to the mixed connective tissue disease.

Authors:  O Epstein; A K Burroughs; S Sherlock
Journal:  J R Soc Med       Date:  1981-06       Impact factor: 5.344

3.  Polymyositis associated with primary biliary cirrhosis.

Authors:  K A Boki; S P Dourakis
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

4.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

5.  Scleroderma, primary biliary cirrhosis, and Sjögren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease.

Authors:  Y Okano; M Nishikai; A Sato
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

6.  A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.

Authors:  J H Ahn; T H Kim; K R Peck; Y W Song
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

7.  Inflammatory Myopathy Associated with Anti-mitochondrial Antibody Presenting Only with Respiratory Failure.

Authors:  Shintaro Fujii; Kazuhiro Horiuchi; Yuki Oshima; Katsuki Eguchi; Azusa Nagai; Ikuko Iwata; Masaaki Matsushima; Ichiro Yabe
Journal:  Intern Med       Date:  2021-06-05       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.